GTBP vs NKE · $17.4M cap vs P/E 35, rev $46.40B
GT Biopharma Inc (GTBP) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
GTBP does not have a complete income-statement cache yet.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
GTBP currently screens at market cap $17.4M. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the GTBP and NKE stock pages for the full models.
Not investment advice.